NONG CHRANG: Open Payments
NPI 1043673379 · SOMERSWORTH, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$362 in 14 payments from 5 companies in 2025. Trend: 2023 $372 · 2024 $599 · 2025 $362
Food & beverage: $362
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $247 |
| AstraZeneca Pharmaceuticals LP | 2 | $46 |
| Lilly USA, LLC | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
| Novo Nordisk Inc | 1 | $23 |
Products named: QULIPTA, UBRELVY, BREZTRI, MOUNJARO, RELISTOR, Wegovy, AIRSUPRA.
Industry payments across NH — which companies pay providers there.
